[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576828":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":85,"collaborators":10,"id":87,"slug":88,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":89,"sex":95,"minAge":96,"maxAge":10,"enrollmentInfo":97,"targetDuration":10,"studyType":100,"phases":10,"briefSummary":101,"conditions":102,"keywords":106,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Inmunotek S.L.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients allergic to hymenoptera venom",null,"Patients allergic to hymenoptera venom and receive the clinical recommendation to be treated with VENOX inmunotherapy (ATC code: V01AA07)",[13],"Biological: VENOX",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"BIOLOGICAL","VENOX","Treatment with allergy vaccine against Vespula spp. (wasp) or Apis mellifera (bee), as per clinical indication.",[9],[21],{"name":22,"affiliation":23,"role":24},"Arantza Vega Castro","University of Guadalajara","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Miguel Casanovas","CONTACT","+34 91208942","mcasanovas@inmunotek.com",{"name":32,"role":28,"phone":33,"phoneExt":10,"email":34},"Raquel Caballero","+34 607600638","rcaballero@inmunotek.com",[36,58,70],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Hospital Universitario Fundación Alcorcón","RECRUITING","Alcorcón","Madrid","28922","Spain","ES",{"type":45,"coordinates":46},"Point",[47,48],-3.82487,40.34582,{"lat":48,"lon":47},[51,55],{"name":52,"role":28,"phone":53,"phoneExt":10,"email":54},"Teresa Alfaya","+34 916219400","teresa.alfaya@salud.madrid.org",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Jesús Macías Iglesias","SUB_INVESTIGATOR",{"facility":59,"status":38,"city":60,"state":10,"zip":10,"country":42,"countryCode":43,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Hospital Reina Sofía","Córdoba",{"type":45,"coordinates":62},[63,64],-4.77275,37.89155,{"lat":64,"lon":63},[67],{"name":68,"role":28,"phone":10,"phoneExt":10,"email":69},"M.ª Berta Ruiz León, Dr","rulebe@gmail.com",{"facility":71,"status":38,"city":72,"state":10,"zip":73,"country":42,"countryCode":43,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Hospital Universitario de Guadalajara","Guadalajara","19002",{"type":45,"coordinates":75},[76,77],-3.16185,40.62862,{"lat":77,"lon":76},[80,83],{"name":22,"role":28,"phone":81,"phoneExt":10,"email":82},"+34 949209200","arantza.vega@gmail.com",{"name":84,"role":57,"phone":10,"phoneExt":10,"email":10},"Juan María Beitia Mazuecos",{"type":86,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100576828","immunotherapy-for-the-treatment-of-hymenoptera-venom-allergy-in-real-life-conditions-100576828",false,"NCT06790368","Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.","Prospective Clinical Follow-up to Evaluate the Safety of Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.","Venox-23","Inclusion Criteria:\n\n* The study population consisted of allergic participants indicated for treatment with hymenoptera venom immunotherapy (Apis mellifera or Vespula spp.) according to standard clinical practice.\n* Participants of both sexes aged 14 years or more.\n* Participants who have not received immunotherapy with hymenoptera venom in the previous 5 years.\n* Participants who have agreed to take part in the study and sign the informed consent form. In the case of minors, the patient's parent or guardian must also sign.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women.\n* Having received immunotherapy with hymenoptera venom during the 5 years prior to the start of the study.\n* Participants who do not agree to participate and\u002For do not sign the informed consent form.\n* Participants who do not comply with medical indications or do not cooperate with immunotherapy treatment.","ALL","14 Years",{"count":98,"type":99},80,"ESTIMATED","OBSERVATIONAL","Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings. This study will be conducted in Spain (multicentric), multicentric and data will be collected prospectively.",[103,104,105],"Allergy, Insect Venom","Allergy Insect Stinging","Insect Sting Allergy",[107,108,109,110,111],"Allergy","Immunotherapy","Apis mellifera","Vespula sp","controlled sting","2025-04-30",{"date":114,"type":115},"2025-05-01","ACTUAL",{"date":117,"type":115},"2025-01-01",{"date":119,"type":99},"2026-06-01",{"name":5,"class":6},3]